The TgF344 AD rat model is a double transgenic with the Swedish mutation and PS1ΔE9 shows strong accumulation of Aβ and NFT at 16 months despite the expression of only endogenous rat tau, not human tau [146, 162]. This evidence concerns the gene MAPT and Alzheimer disease.